Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution
According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.